Federal Watch Center
Stay Informed
Your central resource for federal health plan updates, reimbursement policy changes, prior authorization trends, and access-related guidance affecting pharmaceutical reimbursement professionals.
Your Central Watch Desk for Federal Access & Reimbursement Change
PharmaARMs Federal Watch is designed to help access and reimbursement professionals monitor the federal policy areas that can affect patient access, coverage pathways, prior authorization requirements, benefit design, specialty pharmacy access, site-of-care decisions, and affordability conversations.
This page does not replace official payer policy, plan documents, legal guidance, billing guidance, or medical decision-making. It is a practical watch center that helps reimbursement professionals know where to look, what changed, and what questions to ask.
Featured Federal Updates
Latest Federal Watch Updates
Key federal access, reimbursement, Medicare, and payer-policy developments for review.
Updated: July 16, 2026 CMS Issues Draft Guidance on Manufacturer Effectuation of the Maximum Fair Price in 2028
CMS issued draft guidance describing how manufacturers would provide access to Medicare-negotiated maximum fair prices for selected Part B and Part D drugs beginning in 2028. The guidance includes operational details involving the Medicare Transaction Facilitator, Part B providers, dispensing entities, claim-level data exchange, and manufacturer refund payment workflows.
Access and reimbursement teams should monitor how these requirements may affect provider-administered products, pharmacy and dispensing workflows, acquisition-cost considerations, Medicare Advantage data, and operational readiness for selected drugs under the Medicare Drug Price Negotiation Program.
View CMS Fact Sheet →Updated: July 2, 2026 CMS Launches Medicare GLP-1 Bridge, Expanding Access to GLP-1 Medications
CMS announced a Medicare GLP-1 Bridge initiative designed to expand access to certain GLP-1 medications for eligible Medicare beneficiaries. This update may be relevant for access, reimbursement, benefit investigation, coverage, patient support, pharmacy routing, and payer-policy awareness.
Access teams should distinguish this type of program from standard Part D coverage, including how cost-sharing, prior authorization, pharmacy processing, and out-of-pocket accumulation may be handled.
View CMS Newsroom →Federal Watch Topic Electronic Prior Authorization: What Reimbursement Teams Should Watch in 2026–2027
CMS prior authorization and interoperability requirements continue to shift the access workflow conversation. Reimbursement teams should monitor how electronic prior authorization, payer response timing, API requirements, documentation flow, and provider-office readiness may affect access operations.
This topic is especially important for teams supporting benefit investigations, payer follow-up, prior authorization submissions, denials, appeals, and provider education around access workflow changes.
View CMS Newsroom →Source: Centers for Medicare & Medicaid Services. Always verify final policy details directly on CMS.gov before applying guidance to a specific reimbursement, access, coverage, or operational scenario.
Latest Federal Watch Updates
Source-based updates for pharmaceutical access, reimbursement, payer policy, Medicare, federal benefits, and operational workflow awareness.
Electronic Prior Authorization: What Reimbursement Teams Should Watch in 2026–2027
CMS prior authorization and interoperability requirements are shifting the access workflow conversation. Here are the operational questions ARMs and reimbursement leaders should monitor.
CMS NewsroomMedicare Prescription Payment Plan: Why It Matters for Part D Access Conversations
The Medicare Prescription Payment Plan allows Part D enrollees to spread out-of-pocket prescription drug costs through capped monthly payments. Reimbursement teams should understand where this fits — and where it does not.
CMS NewsroomFEHB Plan Brochures vs. Plan Comparison Tools: What to Verify First
OPM’s comparison tool is useful, but official FEHB brochures remain the controlling benefits source. Here is how access professionals should think about verification.
OPM News ReleasesFederal Watch content is for professional education and workflow awareness only. Always verify final requirements directly with the payer, plan, official government source, provider billing team, or appropriate compliance/legal resource. Do not submit PHI or patient-specific information through PharmaARMs.
Federal Watch Categories
Use these watch categories to follow federal and government-related program updates that may influence access pathways, reimbursement workflows, pharmacy benefit decisions, prior authorization requirements, payer communications, and coverage research.
TRICARE, FEHB & Other Federal Plans
Follow federal plan resources that may affect reimbursement pathways, including TRICARE pharmacy rules, prior authorization requirements, FEHB plan comparisons, prescription drug coverage, and federal employee/retiree benefit considerations.
Medicaid & State Program Watch
Monitor Medicaid pharmacy policy, Medicaid Drug Rebate Program updates, state-level prescription drug coverage variation, drug utilization review, preferred drug list issues, and prior authorization considerations.
Medicare & CMS Updates
Track CMS guidance, Medicare Learning Network resources, billing and compliance education, Medicare Advantage updates, Part D changes, coverage processes, and access-related federal policy developments.
QUICK LINKS TO OFFICIAL RESOURCES
TRICARE / Pharmacy Benefit
TRICARE Pharmacy Formulary, PA & Pharmacy Info
Access TRICARE pharmacy resources including formulary status, prior authorization requirements, medical necessity forms, pharmacy options, home delivery, and provider pharmacy contact information.
Federal Employee Health Benefits
OPM FEHB Plan Compare & Plan Brochures
Access official OPM resources to compare Federal Employees Health Benefits plans, review premiums, search available plans by location, and download plan brochures for benefit details.